Company: VRCA
Filing Date: 2025-03-11
Form Type: S-3
Source: 0001193125-25-052031
Chunk: 17

Company: Verrica Pharmaceuticals Inc.
Filing Date: 2025-03-11
Form: S-3
Chunk 17
---
 period of three years after the date that such stockholder became an interested stockholder, with the following exceptions:

| • |     | before such date, the board of directors of the corporation approved either the business combination or the 
 transaction that resulted in the stockholder becoming an interested stockholder;                            |

| • |     | upon completion of the transaction that resulted in the stockholder becoming an interested stockholder, the                                                                                                                                           
 interested stockholder owned at least 85% of the voting stock of the corporation outstanding at the time the transaction began, excluding for purposes of determining the voting stock outstanding, but not the outstanding voting stock owned by the 
 interested stockholder, those shares owned (1) by persons who are directors and also officers and (2) employee stock plans in which employee participants do not have the right to determine confidentially whether shares held subject to the        
 plan will be tendered in a tender or exchange offer; or                                                                                                                                                                                               |

| • |     | on or after such date, the business combination is approved by the board of directors and authorized at an annual                                                                               
 or special meeting of the stockholders, and not by written consent, by the affirmative vote of at least 662/3% of the outstanding voting stock that is not owned by the interested stockholder. |

In general, Section 203 defines a “business combination” to include the following:

| • |     | any merger or consolidation involving the corporation or any direct or indirect majority-owned subsidiary of the 
 corporation and the interested stockholder;                                                                      |

| • |     | any sale, transfer, pledge or other disposition of 10% or more of the assets of the corporation involving the 
 interested stockholder (in one transaction or a series of transactions);                                      |

| • |     | subject to certain exceptions, any transaction that results in the issuance or transfer by the corporation or by                                         
 any direct or indirect majority-owned subsidiary of the corporation of any stock of the corporation or of such subsidiary to the interested stockholder; |

| • |     | any transaction involving the corporation or any direct or indirect majority-owned subsidiary of the corporation                                                      
 that has the effect of increasing the proportionate share of the stock or any class or series of the corporation beneficially owned by the interested stockholder; or |

11

| • |     | the receipt by the interested stockholder of the benefit of any loans, advances, guarantees, pledges or other 
 financial benefits by or through the corporation.                                                             |

In general, Section 203 defines an “interested